tiprankstipranks
Trending News
More News >
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market

Catalyst Pharma (CPRX) Ratios

Compare
2,519 Followers

Catalyst Pharma Ratios

CPRX's free cash flow for Q4 2025 was $0.91. For the 2025 fiscal year, CPRX's free cash flow was decreased by $ and operating cash flow was $0.47. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
6.08 6.08 5.17 2.88 5.57
Quick Ratio
5.82 5.82 5.01 2.68 5.45
Cash Ratio
4.82 4.82 4.29 1.81 5.18
Solvency Ratio
1.65 1.65 1.63 1.27 1.12
Operating Cash Flow Ratio
1.42 1.42 1.99 1.89 2.02
Short-Term Operating Cash Flow Coverage
477.51 477.51 0.00 0.00 0.00
Net Current Asset Value
$ 741.49M$ 741.49M$ 499.83M$ 137.10M$ 245.60M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.16 1.16 1.17 1.21 1.25
Debt Service Coverage Ratio
558.14 576.26 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
<0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
0.02 0.02 0.03 0.03 0.04
Net Debt to EBITDA
-2.26 -2.20 -2.21 -1.12 -2.86
Profitability Margins
Gross Profit Margin
85.19%85.19%86.00%86.95%83.94%
EBIT Margin
46.79%48.14%39.68%21.80%47.54%
EBITDA Margin
53.16%54.50%47.36%30.06%48.12%
Operating Profit Margin
43.77%43.77%39.68%21.80%47.54%
Pretax Profit Margin
48.14%48.14%43.98%23.73%48.89%
Net Profit Margin
36.39%36.39%33.33%17.93%38.79%
Continuous Operations Profit Margin
36.39%36.39%33.33%17.93%38.79%
Net Income Per EBT
75.60%75.60%75.78%75.56%79.34%
EBT Per EBIT
109.98%109.98%110.83%108.87%102.83%
Return on Assets (ROA)
19.36%19.36%19.25%15.19%22.12%
Return on Equity (ROE)
24.32%22.46%22.52%18.41%27.65%
Return on Capital Employed (ROCE)
26.86%26.86%26.70%22.03%32.02%
Return on Invested Capital (ROIC)
20.30%20.30%20.22%16.63%25.38%
Return on Tangible Assets
21.98%21.98%23.59%25.87%24.21%
Earnings Yield
7.23%7.51%6.63%4.00%4.32%
Efficiency Ratios
Receivables Turnover
4.59 4.59 7.51 7.44 19.85
Payables Turnover
7.79 7.79 4.15 3.51 8.65
Inventory Turnover
2.35 2.35 3.52 3.32 5.05
Fixed Asset Turnover
198.18 198.18 137.20 107.54 59.22
Asset Turnover
0.53 0.53 0.58 0.85 0.57
Working Capital Turnover Ratio
0.80 0.94 1.52 1.96 0.96
Cash Conversion Cycle
188.10 188.10 64.24 55.01 48.42
Days of Sales Outstanding
79.49 79.49 48.61 49.05 18.39
Days of Inventory Outstanding
155.47 155.47 103.60 109.88 72.22
Days of Payables Outstanding
46.86 46.86 87.97 103.92 42.19
Operating Cycle
234.96 234.96 152.21 158.93 90.61
Cash Flow Ratios
Operating Cash Flow Per Share
1.71 1.71 2.02 1.35 1.12
Free Cash Flow Per Share
1.71 1.71 2.02 0.58 1.12
CapEx Per Share
<0.01 <0.01 <0.01 0.77 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 0.43 1.00
Dividend Paid and CapEx Coverage Ratio
3.60K 3.60K 431.31 1.76 4.00K
Capital Expenditure Coverage Ratio
3.60K 3.60K 431.31 1.76 4.00K
Operating Cash Flow Coverage Ratio
74.87 74.87 75.22 40.37 29.80
Operating Cash Flow to Sales Ratio
0.35 0.35 0.49 0.36 0.54
Free Cash Flow Yield
7.00%7.31%9.68%3.46%6.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.83 13.32 15.08 25.02 23.14
Price-to-Sales (P/S) Ratio
5.06 4.85 5.03 4.49 8.98
Price-to-Book (P/B) Ratio
3.11 2.99 3.40 4.61 6.40
Price-to-Free Cash Flow (P/FCF) Ratio
14.28 13.68 10.33 28.88 16.57
Price-to-Operating Cash Flow Ratio
14.21 13.68 10.31 12.44 16.57
Price-to-Earnings Growth (PEG) Ratio
-4.98 0.50 0.14 -1.54 0.21
Price-to-Fair Value
3.11 2.99 3.40 4.61 6.40
Enterprise Value Multiple
7.26 6.69 8.41 13.81 15.80
Enterprise Value
2.27B 2.15B 1.96B 1.65B 1.63B
EV to EBITDA
7.26 6.69 8.41 13.81 15.80
EV to Sales
3.86 3.65 3.98 4.15 7.60
EV to Free Cash Flow
10.90 10.30 8.18 26.72 14.03
EV to Operating Cash Flow
10.89 10.29 8.16 11.51 14.03
Tangible Book Value Per Share
6.73 6.73 4.82 1.82 2.59
Shareholders’ Equity Per Share
7.80 7.80 6.14 3.65 2.91
Tax and Other Ratios
Effective Tax Rate
0.24 0.24 0.24 0.24 0.21
Revenue Per Share
4.82 4.82 4.15 3.75 2.07
Net Income Per Share
1.75 1.75 1.38 0.67 0.80
Tax Burden
0.76 0.76 0.76 0.76 0.79
Interest Burden
1.03 1.00 1.11 1.09 1.03
Research & Development to Revenue
0.02 0.02 0.03 0.23 0.09
SG&A to Revenue
0.22 0.00 0.34 0.12 0.25
Stock-Based Compensation to Revenue
0.04 0.04 0.05 0.04 0.04
Income Quality
0.97 0.97 1.46 2.01 1.40
Currency in USD